Thursday, July 9, 2026

pharma · Chronic Diabetic Foot Ulcers · Diabetic Foot Infection · LABT

Lakewood-Amedex Biotherapeutics

Lakewood-Amedex Biotherapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

University Park, USA HQ
8 Employees
Public company Type
LABT · NYSE Ticker
Company details
Status
Public
HQ
University Park, USA
Employees
8
Programs
4
Drugs
1
Patents
18
Intelligence · Clinical Trials

Lakewood-Amedex Biotherapeutics clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Lakewood-Amedex Biotherapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Lakewood-Amedex Biotherapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Lakewood-Amedex Biotherapeutics.

  1. Antimicrobial agent — Phase 2

    Clinical update
  2. 5% Bisphosphocin Topical Gel — Phase 2

    Clinical update
  3. 5% Nu-3 gel — Phase 2

    Clinical update
  4. Bisphosphocin Nu-3 — Phase 2

    Clinical update

Trial registry

4 studies